Literature DB >> 22453874

From fracture risk prediction to evaluating fracture patterns: recent advances in the epidemiology of osteoporosis.

Nicole C Wright1, Kenneth G Saag.   

Abstract

Understanding the factors associated with fracture is one of the main research objective of the osteoporosis epidemiology field. Tools such as FRAX have overall improved the ability of clinicians and researchers to identify individuals at high risk of fragility fractures. However, the performance of these tools in specific subpopulations needs further examination. We highlight recent studies that have shown under- or overestimation of fractures using FRAX in subpopulations, as well as recently proposed modifications to this important algorithm. We also discuss recent evaluations of secular trends in fracture incidence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453874     DOI: 10.1007/s11926-012-0251-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  46 in total

1.  Official Positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Authors:  Tahir Masud; Neil Binkley; Steven Boonen; Marian T Hannan
Journal:  J Clin Densitom       Date:  2011 Jul-Sep       Impact factor: 2.617

2.  Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.

Authors:  Didier B Hans; John A Kanis; Sanford Baim; John P Bilezikian; Neil Binkley; Jane A Cauley; Juliet E Compston; Cyrus Cooper; Bess Dawson-Hughes; Ghada El-Hajj Fuleihan; William D Leslie; E Michael Lewiecki; Marjorie M Luckey; Eugene V McCloskey; Socrates E Papapoulos; Catalina Poiana; René Rizzoli
Journal:  J Clin Densitom       Date:  2011 Jul-Sep       Impact factor: 2.617

3.  Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®).

Authors:  Edward S Leib; Kenneth G Saag; Jonathan D Adachi; Piet P Geusens; Neil Binkley; Eugene V McCloskey; Didier B Hans
Journal:  J Clin Densitom       Date:  2011 Jul-Sep       Impact factor: 2.617

4.  "'Timed up and go' test and bone mineral density measurement for fracture prediction.

Authors:  Kun Zhu; Amanda Devine; Joshua R Lewis; Satvinder S Dhaliwal; Richard L Prince
Journal:  Arch Intern Med       Date:  2011-10-10

5.  Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.

Authors:  S Kaptoge; L I Benevolenskaya; A K Bhalla; J B Cannata; S Boonen; J A Falch; D Felsenberg; J D Finn; R Nuti; K Hoszowski; R Lorenc; T Miazgowski; I Jajic; G Lyritis; P Masaryk; M Naves-Diaz; G Poor; D M Reid; C Scheidt-Nave; J J Stepan; C J Todd; K Weber; A D Woolf; D K Roy; M Lunt; S R Pye; T W O'neill; A J Silman; J Reeve
Journal:  Bone       Date:  2005-03       Impact factor: 4.398

Review 6.  Pitfalls in the external validation of FRAX.

Authors:  J A Kanis; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2011-11-26       Impact factor: 4.507

7.  Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City.

Authors:  Jing Fang; Ruth Freeman; Rajeswari Jeganathan; Michael H Alderman
Journal:  Ethn Dis       Date:  2004       Impact factor: 1.847

8.  Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan.

Authors:  H Hagino; K Furukawa; S Fujiwara; T Okano; H Katagiri; K Yamamoto; R Teshima
Journal:  Osteoporos Int       Date:  2008-07-17       Impact factor: 4.507

9.  Official Positions for FRAX® clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Authors:  Eugene V McCloskey; Samuel Vasikaran; Cyrus Cooper
Journal:  J Clin Densitom       Date:  2011 Jul-Sep       Impact factor: 2.617

10.  The epidemic of hip fractures: are we on the right track?

Authors:  Klaas A Hartholt; Christian Oudshoorn; Stephanie M Zielinski; Paul T P W Burgers; Martien J M Panneman; Ed F van Beeck; Peter Patka; Tischa J M van der Cammen
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

View more
  2 in total

1.  Risk factors for fracture in middle-age and older-age men of African descent.

Authors:  Yahtyng Sheu; Jane A Cauley; Alan L Patrick; Victor W Wheeler; Clareann H Bunker; Joseph M Zmuda
Journal:  J Bone Miner Res       Date:  2014-01       Impact factor: 6.741

2.  A study to predict fracture risk using bone mineral density and FRAX score in patients on chronic maintenance haemodialysis.

Authors:  Sunil K Patro; Neeraj Pawar; Diwashish Biswas
Journal:  J Family Med Prim Care       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.